Toledo patient receives breakthrough brain treatment

in Community/Health/Local News/People

TOLEDO, Ohio (WTVG) – A Toledo patient was part of a clinical trial aimed at treating brain bleeds with the goal of avoiding repeat surgeries.

The EMBOLISE clinical trial tested whether a new treatment for subdural hematomas, which are brain bleeds most frequently caused by trauma, and is the most common reason for neurosurgery, would lead to lower chances of requiring additional surgery.

“Shutting down this blood vessel with medical glue can actually result in reducing the risk of reaccumulation of blood or the blood becoming more significant to the point where it would require a second surgical evacuation,” said Dr. Mouhammad Jumaa.

Continue Reading On 13abc

Latest from Community

Go to Top